» Articles » PMID: 1714519

Fine Specificity of Cellular Immune Responses in Humans to Human Cytomegalovirus Immediate-early 1 Protein

Overview
Journal J Virol
Date 1991 Sep 1
PMID 1714519
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Cell-mediated immunity is important in maintaining the virus-host equilibrium in persistent human cytomegalovirus (HCMV) infection. The HCMV 72-kDa major immediate early 1 protein (IE1) is a target for CD8+ cytotoxic T cells in humans, as is the equivalent 89-kDa protein in mouse. Less is known about responses against this protein by CD4+ T cells, which may be important as direct effector cells or helper cells for antibody and CD8+ responses. Proliferative-T-cell responses to HCMV IE1 were studied in normal seropositive subjects. Peripheral blood mononuclear cells from 85% of seropositive subjects proliferated in response to HCMV from infected fibroblasts, and of these, 73% responded to recombinant baculovirus IE1. Responding cells were predominantly CD3+ CD4+. IE1 antigen preparations, including baculovirus recombinant protein, transfected rat cell nuclei, and synthetic peptides, induced IE1-specific T-cell lines which cross-reacted between the preparations. The fine specificity of these IE1-specific T-cell lines was studied by using overlapping synthetic peptides encompassing the entire sequence of the IE1 protein. The regions of the IE1 molecule recognized were identified and these varied between individuals, possibly reflecting differences in major histocompatibility complex (MHC) class II haplotype. In one subject, the peptide specificities of proliferative and MHC class I-restricted cytotoxic determinants on IE1 were spatially distinct. Thus, no single immunodominant T-cell determinant within HCMV IE1 was identified, suggesting that multiple peptides or a region of the 72-kDa IE1 protein would be required to induce specific T-cell responses in humans.

Citing Articles

The essential role of guinea pig cytomegalovirus (GPCMV) IE1 and IE2 homologs in viral replication and IE1-mediated ND10 targeting.

Hornig J, Choi K, McGregor A Virology. 2017; 504:122-140.

PMID: 28189970 PMC: 5483178. DOI: 10.1016/j.virol.2017.01.023.


A Diverse Repertoire of CD4 T Cells Targets the Immediate-Early 1 Protein of Human Cytomegalovirus.

Ameres S, Liang X, Wiesner M, Mautner J, Moosmann A Front Immunol. 2015; 6:598.

PMID: 26635812 PMC: 4658442. DOI: 10.3389/fimmu.2015.00598.


Cell-mediated immunity to human CMV infection: a brief overview.

Terrazzini N, Kern F F1000Prime Rep. 2014; 6:28.

PMID: 24860650 PMC: 4018181. DOI: 10.12703/P6-28.


Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2.

Braendstrup P, Mortensen B, Justesen S, Osterby T, Rasmussen M, Hansen A PLoS One. 2014; 9(4):e94892.

PMID: 24760079 PMC: 3997423. DOI: 10.1371/journal.pone.0094892.


Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.

Sylwester A, Mitchell B, Edgar J, Taormina C, Pelte C, Ruchti F J Exp Med. 2005; 202(5):673-85.

PMID: 16147978 PMC: 2212883. DOI: 10.1084/jem.20050882.


References
1.
Klavinskis L, Whitton J, Joly E, Oldstone M . Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology. 1990; 178(2):393-400. DOI: 10.1016/0042-6822(90)90336-p. View

2.
Gotch F, Nixon D, Alp N, McMichael A, Borysiewicz L . High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int Immunol. 1990; 2(8):707-12. DOI: 10.1093/intimm/2.8.707. View

3.
BOOM R, Geelen J, Sol C, Raap A, Minnaar R, Klaver B . Establishment of a rat cell line inducible for the expression of human cytomegalovirus immediate-early gene products by protein synthesis inhibition. J Virol. 1986; 58(3):851-9. PMC: 252992. DOI: 10.1128/JVI.58.3.851-859.1986. View

4.
Cranage M, Kouzarides T, Bankier A, Satchwell S, WESTON K, Tomlinson P . Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO J. 1986; 5(11):3057-63. PMC: 1167261. DOI: 10.1002/j.1460-2075.1986.tb04606.x. View

5.
Wreghitt T, Hicks J, Gray J, OConnor C . Development of a competitive enzyme-linked immunosorbent assay for detecting cytomegalovirus antibody. J Med Virol. 1986; 18(2):119-29. DOI: 10.1002/jmv.1890180204. View